Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Phipps

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2021
Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018Jeremy A W Gold, Emma E Seagle, Joelle Nadle, et al.
Emerging Infectious Diseases|March 20, 2018
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015Sandra N Bulens, Sarah H Yi, Maroya S Walters, et al.
Mbio|January 27, 2021
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant <i>Enterobacterales</i> in the United StatesVictor I Band, Sarah W Satola, Richard D Smith, et al.
Open Forum Infectious Diseases|April 5, 2024
Characteristics of Patients With Initial <i>Clostridioides difficile</i> Infection (CDI) That Are Associated With Increased Risk of Multiple CDI RecurrencesAlice Y Guh, Rongxia Li, Lauren Korhonen, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 16, 2022
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United StatesMaria Karlsson, Joseph D Lutgring, Uzma Ansari, et al.
Emerging Infectious Diseases|June 19, 2019
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015Maroya Spalding Walters, Julian E Grass, Sandra N Bulens, et al.
Open Forum Infectious Diseases|September 8, 2022
Comparison of the Risk of Recurrent <i>Clostridioides Difficile</i> Infections Among Patients in 2018 Versus 2013Alice Y Guh, Sarah H Yi, James Baggs, et al.
JAMA|October 6, 2015
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013Alice Y Guh, Sandra N Bulens, Yi Mu, et al.
Infection Control and Hospital Epidemiology|July 18, 2023
Residential social vulnerability among healthcare personnel with and without severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in Five US states, May-December 2020Maria Zlotorzynska, Nora Chea, Taniece Eure, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2022
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Collected through CDC's Emerging Infections Program, United States, 2016-2018Richard A Stanton, Davina Campbell, Gillian A McAllister, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 3, 2021
Treatment Practices for Adults With Candidemia at 9 Active Surveillance Sites-United States, 2017-2018Jeremy A W Gold, Emma E Seagle, Joelle Nadle, et al.
Emerging Infectious Diseases|March 20, 2018
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015Sandra N Bulens, Sarah H Yi, Maroya S Walters, et al.
Mbio|January 27, 2021
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant <i>Enterobacterales</i> in the United StatesVictor I Band, Sarah W Satola, Richard D Smith, et al.
Open Forum Infectious Diseases|April 5, 2024
Characteristics of Patients With Initial <i>Clostridioides difficile</i> Infection (CDI) That Are Associated With Increased Risk of Multiple CDI RecurrencesAlice Y Guh, Rongxia Li, Lauren Korhonen, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 16, 2022
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United StatesMaria Karlsson, Joseph D Lutgring, Uzma Ansari, et al.
Emerging Infectious Diseases|June 19, 2019
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015Maroya Spalding Walters, Julian E Grass, Sandra N Bulens, et al.
Open Forum Infectious Diseases|September 8, 2022
Comparison of the Risk of Recurrent <i>Clostridioides Difficile</i> Infections Among Patients in 2018 Versus 2013Alice Y Guh, Sarah H Yi, James Baggs, et al.
JAMA|October 6, 2015
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013Alice Y Guh, Sandra N Bulens, Yi Mu, et al.
Infection Control and Hospital Epidemiology|July 18, 2023
Residential social vulnerability among healthcare personnel with and without severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in Five US states, May-December 2020Maria Zlotorzynska, Nora Chea, Taniece Eure, et al.
Antimicrobial Agents and Chemotherapy|September 6, 2022
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Collected through CDC's Emerging Infections Program, United States, 2016-2018Richard A Stanton, Davina Campbell, Gillian A McAllister, et al.
Pageof 10